"10.1371_journal.pone.0013238","plos one","2010-10-08T00:00:00Z","Andrea Mencarelli; Sabrina Cipriani; Barbara Renga; Daniela Francisci; Giuseppe Palladino; Eleonora Distrutti; Franco Baldelli; Stefano Fiorucci","Dipartimento di Medicina Clinica e Sperimentale, University of Perugia, Facoltà di Medicina e Chirurgia, Perugia, Italy; Dipartimento di Medicina Sperimentale e Scienze Biochimiche, University of Perugia, Facoltà di Medicina e Chirurgia, Perugia, Italy; Azienda Ospedaliera di Perugia, Ospedale Santa Maria della Misericordia, Perugia, Italy","Conceived and designed the experiments: DF ED FB SF. Performed the experiments: AM SC BR GP. Analyzed the data: AM SC SF. Wrote the paper: AM SC ED FB SF.","All authors have applied for a use patent in Italy. This patent describes the use of CDCA, the natural FXR ligand described in this manuscript, as a potential treatment for dyslipidemia caused by HIV protease inhibitors. The study was not supported by any commercial entity and has no commercial bias. Please note that the patent is not submitted yet and is not granted yet. The patent does not contain any matter composition and does not include protection of any property by the authors. It does not interfere with the ethics of the studys conduct and interpretation of data or their representation.","2010","10","Andrea Mencarelli","AM",8,TRUE,4,4,3,5,TRUE,TRUE,FALSE,0,NA,FALSE
